Homoharringtonine is safe and effective for patients with acute myelogenous leukemia

Leukemia

Volumn 6, Issue 11, 1992, Pages 1185-1188

  Feldman, E ^a   Arlin, Z ^a   Ahmed, T ^a   Mittelman, A ^a   Puccio, C ^a   Chun, H ^a   Cook, P ^a   Baskind, P ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYTARABINE; HOMOHARRINGTONINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; BONE MARROW SUPPRESSION; CANCER RECURRENCE; CANCER RESISTANCE; CHRONIC MYELOID LEUKEMIA; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; FLUID RETENTION; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; VOMITING; WEIGHT GAIN;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; HARRINGTONINES; HUMAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID, CHRONIC; RECURRENCE;

EID: 0026499322     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chinese People's Liberation Army 187th Hospital. Harringtonine in acute leukemia: clinical analysis of 31 cases. Chin Med J 1977;3:319-324.
2. Chinese People's Liberation Army 187th Hospital. Homoharringtonine in the treatment of leukemia: clinical analyses of 72 cases. Chin Med J 1978;3:163-166.
3. Hematology Research Division and Hematology Section of the Children's Hospital, Suzhow Medical College, Suzhow. High remission induction (traditional Sino-Western HOAP) regimen for acute nonlymphocytic leukemia. Chin Med J 1980;93:565-568.
4. Neidhart JA, Young DC, Derocher D, Metz E. Phase I trial of homoharringtonine. Cancer Treat Rep 1983;67: 801-804.
5. Warrell RP Jr, Coonley CJ, Gee TS. Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia. J Clin Oncol 1985;3:617-621.
6. Miller AB, Hoogstraton B, Staquert M, Winkler A. Reporting results of cancer therapy. Cancer 1981;47: 207-214.
7. Jing-Song Y, Xiao-Hong W, Guang-Hui F, Gui-Ren L, Zhi-Ping L. Small dose harringtonine induces complete remission in patients with acute promyelocytic leukemia. Leukemia 1988;2:427-429.
8. Kantarjian HM, Keating MJ, Walters RS, Koller CA, McCredie KB, Freireich EJ. Phase II study of low-dose continuous infusion homoharringtonine in refractory acute myelogenous leukemia. Cancer 1989;63(5):813-817.
9. Stewart JA, Cassileth PA, Bennett JM, O'Connell MJ. Continuous infusion homoharringtonine in refractory acute nonlymphocytic leukemia. An ECOG pilot study. Am J Clin Oncol 1988;11(6):627-629.
10. 1) chronic myelogenous leukemia (CML). Proc Am Soc Hematol 1991.
11. Legha SS, Keating M, Picket S, Ajani JA, Ewer M, Bodey GP. Phase I clinical investigation of homoharringtonine. Cancer Treat Rep 1984;68:1085-1091.
12. Feldman E, Ahmed T, Mittelman A et al. Phase II trial of homoharringtonine (HHT) in patients with myelodysplastic syndrome (MDS) and MDS evolving to acute nonlymphocytic leukemia (ANLL). Proc Am Soc Clin Oncol 1991;10:228.
13. Cephalotaxus Research Coordinating Group. Cephalotaxine esters in the treatment of acute leukemia. A preliminary clinical assessment. Chin Med 1976;2:263-272.
14. Sylvester RK, Lobell M, Ogden W, Stewart JA. Homoharringtonine-induced hyperglycemia. J Clin Oncol 1989; 7(3):392-395.
15. Warrell RP Jr, Berman E. Etoposide (VP-16) does not increase remission induction with homoharringtonine (HHT) in patients with acute non-lymphoblastic leukemia (ANLL). Proc Am Assoc Cancer Res 1986;27:192 (Abstr).
16. Haines IE, Lowenthal DA, Warrell RP, Berman E, Kempin SJ. Homoharringtonine and amsacrine in pretreated patients with acute non-lymphocytic leukemia. Proc Am Soc Clin Oncol 1987;5:542.
17. Arlin Z, Feldman E, Ahmed T, Amorosi E, Ascensao J, Mittelman A, Puccio C, Baskind P. Phase I trial of homoharringtonine with cytarabine in patients with acute myelogenous leukemia (AML). Proc Am Soc Clin Oncol 1989;8:202.